Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
2,052
Value
$1.02M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of VRTX by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,052$1.02M<0.1%00.0%UnchangedHolders
Q1 20262,052$916.3K<0.1%−51−2.4%ReducedHolders
Q4 20252,103$953.3K<0.1%−30−1.4%ReducedHolders
Q3 20252,133$835.3K<0.1%−65−3.0%ReducedHolders
Q2 20252,198$978.5K<0.1%−3,623−62.2%ReducedHolders
Q1 20255,821$2.82M<0.1%−914−13.6%ReducedHolders
Q4 20246,735$2.71M<0.1%−340−4.8%ReducedHolders
Q3 20247,075$3.29M0.1%−12,330−63.5%ReducedHolders
Q2 202419,405$9.10M0.2%+17,389+862.5%AddedHolders
Q1 20242,016$842.7K<0.1%−6−0.3%ReducedHolders
Q4 20232,022$822.7K<0.1%+1,975+4,202.1%AddedHolders
Q3 202347$16.3K<0.1%+25+113.6%AddedHolders
Q2 202322$7.74K<0.1%00.0%UnchangedHolders
Q1 202322$6.93K<0.1%+22NewHolders
Q4 20220$00.0%−12−100.0%Sold outHolders
Q3 202212$3.00K<0.1%−3−20.0%ReducedHolders
Q2 202215$4.00K<0.1%+3+25.0%AddedHolders
Q1 202212$3.00K<0.1%+12NewHolders
Q4 20210$00.0%−35−100.0%Sold outHolders
Q3 202135$6.00K<0.1%+35NewHolders
Q2 20210$00.0%−107−100.0%Sold outHolders
Q1 2021107$23.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.